Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleOriginal Article

Inhibition of Cardiac Hypertrophy by Triflusal (4-Trifluoromethyl Derivative of Salicylate) and Its Active Metabolite

Anna Planavila, Ricardo Rodríguez-Calvo, Alberto Fernández de Arriba, Rosa M. Sánchez, Juan C. Laguna, Manuel Merlos and Manuel Vazquez-Carrera
Molecular Pharmacology April 2006, 69 (4) 1174-1181; DOI: https://doi.org/10.1124/mol.105.016345
Anna Planavila
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ricardo Rodríguez-Calvo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Fernández de Arriba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosa M. Sánchez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan C. Laguna
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuel Merlos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuel Vazquez-Carrera
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 69 no. 4 1174-1181
DOI 
https://doi.org/10.1124/mol.105.016345
PubMed 
16421291

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received June 30, 2005
  • Accepted January 18, 2006
  • Published online March 21, 2006.

Article Versions

  • Earlier version (January 18, 2006 - 11:41).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Anna Planavila,
  2. Ricardo Rodríguez-Calvo,
  3. Alberto Fernández de Arriba,
  4. Rosa M. Sánchez,
  5. Juan C. Laguna,
  6. Manuel Merlos and
  7. Manuel Vazquez-Carrera
  1. Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Faculty of Pharmacy, University of Barcelona, Spain (A.P., R.R.-C., R.M.S., J.C.L., M.M., M.V.-C.); and the Department of Pharmacology, Uriach Research Center, Barcelona, Spain (A.F.d.A., M.M.)
  1. Address correspondence to:
    Dr. Manuel Vázquez-Carrera, Unitat de Farmacologia, Facultat de Farmàcia, Diagonal 643, E-08028 Barcelona, Spain. E-mail: mvazquezcarrera{at}ub.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 2006 to July 2022

AbstractFullPdf
Jan 20069069
Feb 200619080
Mar 2006411466
Apr 2006181211
May 200612189
Jun 20062077
Jul 20069916
Aug 2006974
Sep 200610128
Oct 2006121117
Nov 200617616
Dec 20061049
Jan 20076128
Feb 20077818
Mar 200713914
Apr 2007202114
May 200771920
Jun 200791921
Jul 200762420
Aug 200742123
Sep 200712015
Oct 2007102412
Nov 2007105427
Dec 20071099
Jan 200871418
Feb 2008141721
Mar 2008191414
Apr 200881315
May 2008201619
Jun 2008173125
Jul 2008252318
Aug 2008462310
Sep 2008412410
Oct 2008883
Nov 2008371910
Dec 200834307
Jan 2009362515
Feb 2009151619
Mar 200919209
Apr 20091163
May 200981615
Jun 200941010
Jul 2009161910
Aug 200991115
Sep 20094138
Oct 2009768
Nov 200910219
Dec 20091518
Jan 201025613
Feb 2010868
Mar 201018116
Apr 201081715
May 2010121713
Jun 2010121610
Jul 2010996
Aug 201016104
Sep 201082110
Oct 2010101110
Nov 2010111013
Dec 2010775
Jan 20114713
Feb 2011161015
Mar 201113910
Apr 2011987
May 201161110
Jun 2011555
Jul 20112157
Aug 20117812
Sep 20111185
Oct 201122109
Nov 2011231215
Dec 20112186
Jan 2012979
Feb 20121868
Mar 201218910
Apr 201211139
May 201215414
Jun 201271015
Jul 201219815
Aug 20129718
Sep 20128136
Oct 201213511
Nov 201271414
Dec 2012939
Jan 20131987
Feb 2013994
Mar 201311168
Apr 20138138
May 2013161111
Jun 20135175
Jul 201312103
Aug 2013545
Sep 20131043
Oct 2013541
Nov 20131222
Dec 201331311
Jan 201471114
Feb 20149710
Mar 2014765
Apr 20147104
May 2014161015
Jun 20148129
Jul 2014673
Aug 201461617
Sep 201431311
Oct 201462117
Nov 201415156
Dec 20141086
Jan 20159119
Feb 20158137
Mar 201581311
Apr 2015653
May 20151376
Jun 2015111218
Jul 201592011
Aug 20156142
Sep 20154153
Oct 20155810
Nov 2015262
Dec 20154126
Jan 20161639
Feb 2016984
Mar 201691013
Apr 2016463
May 2016676
Jun 20162214
Jul 2016774
Aug 2016984
Sep 2016974
Oct 20160123
Nov 20161154
Dec 20161186
Jan 20170196
Feb 20170163
Mar 201711511
Apr 201702018
May 20170153
Jun 20170145
Jul 20173193
Aug 20170200
Sep 2017291
Oct 20171165
Nov 20170203
Dec 20170135
Jan 20181172
Feb 20181154
Mar 20180193
Apr 20180234
May 20180212
Jun 20181183
Jul 20183131
Aug 2018181
Sep 2018092
Oct 20180130
Nov 2018081
Dec 20181611
Jan 2019700
Feb 20191410
Mar 2019201
Apr 20192228
May 2019502
Jun 2019802
Jul 20191400
Aug 2019900
Sep 20191001
Oct 2019900
Nov 2019900
Dec 2019805
Jan 2020904
Feb 2020800
Mar 2020500
Apr 2020500
May 2020400
Jun 2020400
Jul 2020600
Aug 2020401
Sep 2020200
Oct 20201001
Nov 2020401
Dec 20201011
Jan 2021732
Feb 2021513
Mar 20213110
Apr 2021710
May 2021522
Jun 2021410
Jul 2021603
Aug 2021810
Sep 2021410
Oct 2021511
Nov 2021921
Dec 20211512
Jan 20221410
Feb 2022410
Mar 2022350
Apr 20221010
May 2022810
Jun 20221120
Jul 2022600

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 69 (4)
Molecular Pharmacology
Vol. 69, Issue 4
1 Apr 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Inhibition of Cardiac Hypertrophy by Triflusal (4-Trifluoromethyl Derivative of Salicylate) and Its Active Metabolite
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleOriginal Article

Inhibition of Cardiac Hypertrophy by Triflusal (4-Trifluoromethyl Derivative of Salicylate) and Its Active Metabolite

Anna Planavila, Ricardo Rodríguez-Calvo, Alberto Fernández de Arriba, Rosa M. Sánchez, Juan C. Laguna, Manuel Merlos and Manuel Vazquez-Carrera
Molecular Pharmacology April 1, 2006, 69 (4) 1174-1181; DOI: https://doi.org/10.1124/mol.105.016345

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleOriginal Article

Inhibition of Cardiac Hypertrophy by Triflusal (4-Trifluoromethyl Derivative of Salicylate) and Its Active Metabolite

Anna Planavila, Ricardo Rodríguez-Calvo, Alberto Fernández de Arriba, Rosa M. Sánchez, Juan C. Laguna, Manuel Merlos and Manuel Vazquez-Carrera
Molecular Pharmacology April 1, 2006, 69 (4) 1174-1181; DOI: https://doi.org/10.1124/mol.105.016345
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The 73-kDa Heat Shock Cognate Protein Is a CXCR4 Binding Protein that Regulates the Receptor Endocytosis and the Receptor-Mediated Chemotaxis
  • Endogenous Regulator of G-Protein Signaling Proteins Regulate the Kinetics of Gαq/11-Mediated Modulation of Ion Channels in Central Nervous System Neurons
  • A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular Signaling
Show more ORIGINAL ARTICLE

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics